Periodic updates of NMPA (National Medical Products Administration) registration for Class III medical devices in China involve several steps and considerations to ensure ongoing compliance and regulatory approval. Here’s an overview of the standards and process for these updates:

1. Understanding Periodic Updates

• Purpose: Periodic updates are necessary to maintain the validity of your NMPA registration and ensure that regulatory authorities have current information about your device's safety, efficacy, and quality.

• Timing: Updates typically occur annually as part of the renewal process or as required by specific regulatory notifications.

2. Standards and Regulatory Requirements

• ISO 13485: Maintain ISO 13485 certification or equivalent QMS certification recognized by the NMPA. Compliance with QMS standards ensures that your device manufacturing processes continue to meet regulatory expectations.

• GB Standards: Adhere to relevant Chinese national standards (GB standards) that apply to your medical device category, including safety, performance, and testing requirements.

3. Process for Periodic Updates

• Documentation Review: Conduct a comprehensive review of all technical documentation, including device specifications, manufacturing processes, labeling, and IFU (Instructions for Use). Ensure that all documentation is accurate, up-to-date, and compliant with current regulatory standards.

• Clinical Data Updates: Provide updates on any new clinical data, including post-market surveillance (PMS) studies or post-market clinical follow-up (PMCF) data, if applicable. This data helps demonstrate ongoing device safety and efficacy.

• Quality Management System (QMS): Submit updated QMS documentation, including any changes or improvements made to your QMS processes and procedures.

• Labeling and Advertising: Update device labeling and promotional materials as necessary to reflect any changes approved by the NMPA. Ensure compliance with labeling requirements specified in Chinese regulations.

• Notification of Changes: Notify the NMPA of any significant changes to device design, manufacturing processes, suppliers, or facilities that may impact device safety, performance, or regulatory compliance. Obtain NMPA approval for these changes as required.

4. Submission and Approval Process

• Prepare Application: Compile all updated documentation into a comprehensive application package. Ensure that the application is complete, accurate, and aligned with NMPA submission requirements.

• Submission: Submit the application for periodic update through the NMPA's designated online portal or via physical submission to the NMPA office. Follow specific instructions provided by the NMPA for submission procedures.

• Review and Approval: The NMPA will review your application, including technical documentation, clinical data updates, and QMS documentation. They may request additional information or clarifications during the review process.

• Decision: Upon successful review, the NMPA will issue an updated registration certificate or notification confirming the validity of your device registration.

5. Post-Approval Responsibilities

• Compliance Monitoring: Continuously monitor regulatory updates and requirements to ensure ongoing compliance with NMPA regulations.

• Adverse Event Reporting: Maintain procedures for monitoring and reporting adverse events related to your device as required by Chinese regulations.

• Annual Reporting: Submit annual reports to the NMPA detailing device sales, adverse events, and updates on post-market surveillance activities.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn